Effect of triglyceride structure on fecal excretion of 13c-labeled triglycerides

Journal of the American College of Nutrition

Volumn 22, Issue 6, 2003, Pages 511-518

  Schuette, Sally A ^a   Janghorbani, Morteza ^a,b   Cohen, Mitchell B ^c   Krug, Susan ^c   Schindler, Terri ^c   Wagner, David A ^d   DiMagno, Eugene P ^e  

^a Biochemanalysis Corporation   (United States)

^b Ctr for Stable Isotope Res Inc   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d METABOLIC SOLUTIONS INC   (United States)

^e MAYO CLINIC   (United States)

Author keywords

13C label; Chronic pancreatitis; Cystic fibrosis; Malabsorption; Triglyceride structure

Indexed keywords

CARBON 13; DYSPROSIUM; FECES LIPID; TRIACYLGLYCEROL;

ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYSTIC FIBROSIS; FECES; FEMALE; HUMAN; INTESTINE TRANSIT TIME; ISOTOPE LABELING; MALE; PANCREAS FUNCTION; STEATORRHEA; TEST MEAL;

ADOLESCENT; ADULT; AGED; CARBON ISOTOPES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYSTIC FIBROSIS; DIETARY FATS; FECES; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OHIO; PANCREATITIS; SEVERITY OF ILLNESS INDEX; STEATORRHEA; TIME FACTORS; TRIGLYCERIDES;

EID: 0348147662     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2003.10719329     Document Type: Article

References (27)

1. Westergaard H: Differential approach to steatorrhea. In Dietschy (ed): “Disorders of the Gastrointestinal Tract, Disorders of the Liver, Nutritional Disorders.” New York: Grune & Stratton, pp 76-80, 1976.
2. Couper R: Pancreatic function tests. In Walker WA (ed): “Pediatric Gastrointestinal Disease.” Ontario: BC Decker, pp 1515-1528, 2000.
3. Owyang C, Levvitt MD: Chronic pancreatitis. In Yamada T (ed) “Textbook of Gastroenterology.” Philadelphia: JB Lipponcott Co, pp.2091-2112, 1995.
4. DiMagno EP, Go VL, Summerskill WH: Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813-815, 1978.
5. Regan PT, Malagelada JR, DiMagno EP, Glanzman SL, Go VL: Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854-858, 1977.
6. Small DM: The effects of glyceride structure on absorption and metabolism. Ann Rev Nutr 11:413-434, 1991.
7. Bracco U: Effect of triglyceride structure on fat absorption. Am J Clin Nutr 60(Suppl):1102S-1109S, 1994.
8. Hashim SA, Babayan VK: Studies in man of partially absorbed dietary fats. Am J Clin Nutr 31(Suppl):273S-276S, 1978.
9. Schuette SA, Janghorbani M, Cohen MB, Krug S, Schindler T, Wagner DA, Morris SJ: Dysprosium chloride as a nonabsorbable gastrointestinal marker for studies of stable isotope-labeled triglyceride excretion in man. J Am Coll Nutr 22: 379-387, 2003.
10. Layer P, Yamamoto H, Kalthoff L, ClainJE, Bakken LJ, DiMagno EP: The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 107:1481-1487, 1994.
11. Maringhini A, Nelson DK, Jones JD, DiMagno EP: Is the plasma amino acid consumption test an accurate test of exocrine pancreatic insufficiency? Gastroenterol 106:488-493, 1994.
12. Jeejeebhoy KN, Ahmad S, Kozak G: Determination of fecal fats containing both medium and long chain triglycerides and fatty acids. Clin Biochem 3:157-163, 1970.
13. Tietz NW: “Textbook of Clinical Chemistry.” Philadelphia: WB Saunders, 1986.
14. van de Kamer JH, Huinick HTB, Weyers HA: Rapid method for the determination of fat in feces. J Biol Chem 177:347-355, 1949.
15. Schuette SA, Janghorbani M, Young VR, Weaver CM: Dysprosium as a nonabsorbable marker for studies of mineral absorption with stable isotope tracers in human subjects. J Am Coll Nutr 12:307-315, 1993.
16. Pedersen NT: Estimation of lipid assimilation from faecal samples using 14C-triolein as tracer and 51CrCl3 as non-absorbable marker. Scan J Clin Lab Med 43:323-328, 1983.
17. Ditchburn RK, Smith AH, Hayter CJ: Use of unabsorbed radioactive marker substances in a reassessment of the radioactive triolein test of fat absorption. J Clin Path 24:506-514, 1971.
18. Henry RJ, Cannon DC, Winkelman JW: “Clinical Chemistry; Principles and Techniques.” New York: Harper & Row, pp.1475-1483, 1974.
19. Kalivianakis M, Minich DM, Bijleveld CMA, van Aalderen WMC, Stellaard F, Laseur M, Vonk R, Verkade HJ: Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 69:127-134, 1999.
20. Watkins JB, Klein PD, Schoeller DA, Kirschner BS, Park R, Perman JA: Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath tests. Gastroenterology 82:911-917, 1982.
21. Murphy JL, Jones AE, Stolinski M, Wootton SA: Gastrointestinal handling of [1-13C] palmitic acid in healthy controls and patients with cystic fibrosis. Arch Dis Child 76:425-427, 1997.
22. Greenberger NJ, Skillman TG: Medium-chain triglycerides. N Engl J Med 280:1045-1058, 1969.
23. Durie PR, Newth CJ, Forstner GG, Gall DG: Malabsorption of medium-chain triglycerides in infants with cystic fibrosis: Correction with pancreatic enzyme supplements. J Pediatr 96:862-864, 1980.
24. Slater C, Ling SC, Preston T, Weaver LT: Analysis of 13C-mixed triacylglycerol in stool by bulk (EA-IRMS) and compound specific (GC/MS) methods. Isotopes Environ Health Stud 38:79-86, 2002.
25. Gaskin K: Exocrine pancreatic dysfunction 1. Cystic fibrosis. In Walker WA (ed): “Pediatric Gastrointestinal Disease,” Ontario: BC Decker, pp. 1353-1370, 2000.
26. Pedersen NT, Halgreen H: Simultaneous assessment of fat maldigestion and fat malabsorption by a double-isotope method using fecal radioactivity. Gastroenterology 88:47-54, 1985.
27. Murphy JL, Laicho KM, Jones AE, Wootton SA: Metabolic handling of 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis. Arch Dis Child 79:44-47, 1998.